Journal article
Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction
The Journal of immunology (1950), Vol.192(12), pp.5863-5872
06/15/2014
DOI: 10.4049/jimmunol.1203230
PMCID: PMC4052223
PMID: 24808365
Abstract
Leishmania major-infected human dendritic cells (DCs) exhibit a marked induction of IL-12, ultimately promoting a robust Th1-mediated response associated with parasite killing and protective immunity. The host cell transcription machinery associated with the specific IL-12 induction observed during L. major infection remains to be thoroughly elucidated. In this study, we used Affymetrix GeneChip (Affymetrix) to globally assess the host cell genes and pathways associated with early L. major infection in human myeloid-derived DCs. Our data revealed 728 genes were significantly differentially expressed and molecular signaling pathway revealed that the type I IFN pathway was significantly enriched. Addition of a neutralizing type I IFN decoy receptor blocked the expression of IRF7 and IL-12p40 during DC infection, indicating the L. major-induced expression of IL-12p40 is dependent upon the type I IFN signaling pathway. In stark contrast, IL-12p40 expression is not elicited by L. donovani, the etiological agent of deadly visceral leishmaniasis. Therefore, we examined the gene expression profile for several IFN response genes in L. major versus L. donovani DC infections. Our data revealed that L. major, but not L. donovani, induces expression of IRF2, IRF7, and IFIT5, implicating the regulation of type I IFN-associated signaling pathways as mediating factors toward the production of IL-12.
Details
- Title: Subtitle
- Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction
- Creators
- Michelle A Favila - Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556; andNicholas S Geraci - Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556; andErliang Zeng - Genomics and Bioinformatics Core Facility, University of Notre Dame, Notre Dame, IN 46556Brent Harker - Genomics and Bioinformatics Core Facility, University of Notre Dame, Notre Dame, IN 46556David Condon - Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556; andRachel N Cotton - Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556; andAsha Jayakumar - Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556; andVinita Tripathi - Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556; andMary Ann McDowell - Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, IN 46556; and mcdowell.11@nd.edu
- Resource Type
- Journal article
- Publication Details
- The Journal of immunology (1950), Vol.192(12), pp.5863-5872
- DOI
- 10.4049/jimmunol.1203230
- PMID
- 24808365
- PMCID
- PMC4052223
- NLM abbreviation
- J Immunol
- ISSN
- 0022-1767
- eISSN
- 1550-6606
- Publisher
- United States
- Grant note
- R01AI056242 / NIAID NIH HHS T32GM075762 / NIGMS NIH HHS R01 AI056242 / NIAID NIH HHS K22 AI054343 / NIAID NIH HHS T32 GM075762 / NIGMS NIH HHS
- Language
- English
- Date published
- 06/15/2014
- Academic Unit
- Preventive and Community Dentistry; Roy J. Carver Department of Biomedical Engineering; Iowa Neuroscience Institute; Biostatistics; Dental Research
- Record Identifier
- 9984065465902771
Metrics
24 Record Views